O	0	15	Thermostability	Thermostability	NN	B-NP
O	16	19	and	and	CC	I-NP
O	20	29	molecular	molecular	JJ	I-NP
O	30	43	encapsulation	encapsulation	NN	I-NP
O	44	50	within	within	IN	B-PP
O	51	53	an	an	DT	B-NP
O	54	64	engineered	engineer	VBN	I-NP
O	65	70	caged	cage	VBN	I-NP
O	71	78	protein	protein	NN	I-NP
O	79	87	scaffold	scaffold	RB	B-ADVP
O	87	88	.	.	.	O

O	89	93	Self	Self	NN	B-NP
O	93	94	-	-	HYPH	O
O	94	104	assembling	assemble	VBG	B-VP
O	105	115	biological	biological	JJ	B-NP
O	116	125	complexes	complex	NNS	I-NP
O	126	130	such	such	JJ	B-PP
O	131	133	as	as	IN	I-PP
O	134	139	viral	viral	JJ	B-NP
O	140	147	capsids	capsid	NNS	I-NP
O	148	152	have	have	VBP	B-VP
O	153	157	been	be	VBN	I-VP
O	158	169	manipulated	manipulate	VBN	I-VP
O	170	172	to	to	TO	I-VP
O	173	181	function	function	VB	I-VP
O	182	184	in	in	IN	B-PP
O	185	195	innovative	innovative	JJ	B-NP
O	196	210	nanotechnology	nanotechnology	NN	I-NP
O	211	223	applications	application	NNS	I-NP
O	223	224	.	.	.	O

O	225	228	The	The	DT	B-NP
O	229	231	E2	E2	NN	I-NP
O	232	241	component	component	NN	I-NP
O	242	244	of	of	IN	B-PP
O	245	253	pyruvate	pyruvate	NN	B-NP
O	254	267	dehydrogenase	dehydrogenase	NN	I-NP
O	268	272	from	from	IN	B-PP
O	273	281	Bacillus	Bacillus	NN	B-NP
O	282	300	stearothermophilus	stearothermophilus	NN	I-NP
O	301	306	forms	form	VBZ	B-VP
O	307	308	a	a	DT	B-NP
O	309	321	dodecahedral	dodecahedral	JJ	I-NP
O	322	329	complex	complex	NN	I-NP
O	330	333	and	and	CC	O
O	334	345	potentially	potentially	RB	B-VP
O	346	354	provides	provide	VBZ	I-VP
O	355	362	another	another	DT	B-NP
O	363	371	platform	platform	NN	I-NP
O	372	375	for	for	IN	B-PP
O	376	381	these	these	DT	B-NP
O	382	390	purposes	purpose	NNS	I-NP
O	390	391	.	.	.	O

O	392	394	In	In	IN	B-PP
O	395	399	this	this	DT	B-NP
O	400	413	investigation	investigation	NN	I-NP
O	413	414	,	,	,	O
O	415	417	we	we	PRP	B-NP
O	418	422	show	show	VBP	B-VP
O	423	427	that	that	IN	B-SBAR
O	428	432	this	this	DT	B-NP
O	433	440	protein	protein	NN	I-NP
O	441	449	assembly	assembly	NN	I-NP
O	450	458	exhibits	exhibit	VBZ	B-VP
O	459	466	unusual	unusual	JJ	B-NP
O	467	476	stability	stability	NN	I-NP
O	477	480	and	and	CC	O
O	481	484	can	can	MD	B-VP
O	485	487	be	be	VB	I-VP
O	488	496	modified	modify	VBN	I-VP
O	497	499	to	to	TO	B-VP
O	500	511	encapsulate	encapsulate	VB	I-VP
O	512	517	model	model	NN	B-NP
O	518	522	drug	drug	NN	I-NP
O	523	532	molecules	molecule	NNS	I-NP
O	532	533	.	.	.	O

O	534	536	To	To	TO	B-VP
O	537	544	distill	distill	VB	I-VP
O	545	548	the	the	DT	B-NP
O	549	551	E2	E2	NN	I-NP
O	552	559	protein	protein	NN	I-NP
O	560	564	down	down	IN	B-PP
O	565	567	to	to	TO	B-PP
O	568	571	its	its	PRP$	B-NP
O	572	582	structural	structural	JJ	I-NP
O	583	591	scaffold	scaffold	JJ	I-NP
O	592	596	core	core	NN	I-NP
O	596	597	,	,	,	O
O	598	600	we	we	PRP	B-NP
O	601	612	synthesized	synthesize	VBD	B-VP
O	613	614	a	a	DT	B-NP
O	615	624	truncated	truncate	VBN	I-NP
O	625	629	gene	gene	NN	I-NP
O	630	639	optimized	optimize	VBN	B-VP
O	640	643	for	for	IN	B-PP
O	644	654	expression	expression	NN	B-NP
O	655	657	in	in	IN	B-PP
O	658	669	Escherichia	Escherichia	NNP	B-NP
O	670	674	coli	coli	NNP	I-NP
O	674	675	.	.	.	O

O	676	679	The	The	DT	B-NP
O	680	687	correct	correct	JJ	I-NP
O	688	696	assembly	assembly	NN	I-NP
O	697	700	and	and	CC	O
O	701	713	dodecahedral	dodecahedral	JJ	B-NP
O	714	723	structure	structure	NN	I-NP
O	724	726	of	of	IN	B-PP
O	727	730	the	the	DT	B-NP
O	731	740	resulting	result	VBG	I-NP
O	741	749	scaffold	scaffold	NN	I-NP
O	750	753	was	be	VBD	B-VP
O	754	763	confirmed	confirm	VBN	I-VP
O	764	768	with	with	IN	B-PP
O	769	776	dynamic	dynamic	JJ	B-NP
O	777	782	light	light	JJ	I-NP
O	783	793	scattering	scattering	NN	I-NP
O	794	797	and	and	CC	O
O	798	810	transmission	transmission	NN	B-NP
O	811	819	electron	electron	NN	I-NP
O	820	830	microscopy	microscopy	NN	I-NP
O	830	831	.	.	.	O

O	832	837	Using	Use	VBG	B-VP
O	838	846	circular	circular	JJ	B-NP
O	847	856	dichroism	dichroism	NN	I-NP
O	857	860	and	and	CC	O
O	861	873	differential	differential	JJ	B-NP
O	874	882	scanning	scanning	NN	I-NP
O	883	894	calorimetry	calorimetry	NN	I-NP
O	894	895	,	,	,	O
O	896	898	we	we	PRP	B-NP
O	899	904	found	find	VBD	B-VP
O	905	908	the	the	DT	B-NP
O	909	924	thermostability	thermostability	NN	I-NP
O	925	927	of	of	IN	B-PP
O	928	931	the	the	DT	B-NP
O	932	939	complex	complex	NN	I-NP
O	940	942	to	to	TO	B-VP
O	943	945	be	be	VB	I-VP
O	946	955	unusually	unusually	RB	B-ADJP
O	956	960	high	high	JJ	I-ADJP
O	960	961	,	,	,	O
O	962	966	with	with	IN	B-PP
O	967	969	an	an	DT	B-NP
O	970	975	onset	onset	NN	I-NP
O	976	987	temperature	temperature	NN	I-NP
O	988	990	of	of	IN	B-PP
O	991	1000	unfolding	unfold	VBG	B-VP
O	1001	1003	at	at	IN	B-PP
O	1004	1006	81	81	CD	B-NP
O	1006	1007	.	.	.	O
O	1007	1008	1	1	CD	B-NP
O	1009	1010	+	+	SYM	O
O	1010	1011	/	/	SYM	O
O	1011	1012	-	-	SYM	B-NP
O	1013	1014	0	0	CD	B-NP
O	1014	1015	.	.	.	I-NP
O	1015	1016	9	9	CD	I-NP
O	1017	1024	degrees	degree	NNS	I-NP
O	1025	1026	C	C	NN	I-NP
O	1027	1030	and	and	CC	O
O	1031	1033	an	an	DT	B-NP
O	1034	1042	apparent	apparent	JJ	I-NP
O	1043	1051	midpoint	midpoint	NN	I-NP
O	1052	1061	unfolding	unfold	VBG	B-VP
O	1062	1073	temperature	temperature	NN	B-NP
O	1074	1076	of	of	IN	B-PP
O	1077	1079	91	91	CD	B-NP
O	1079	1080	.	.	.	O
O	1080	1081	4	4	CD	B-NP
O	1082	1083	+	+	SYM	O
O	1083	1084	/	/	SYM	B-NP
O	1084	1085	-	-	SYM	B-NP
O	1086	1087	1	1	CD	I-NP
O	1087	1088	.	.	.	I-NP
O	1088	1089	4	4	CD	I-NP
O	1090	1097	degrees	degree	NNS	I-NP
O	1098	1099	C	C	JJ	B-ADJP
O	1099	1100	.	.	.	O

O	1101	1103	To	To	TO	B-VP
O	1104	1112	evaluate	evaluate	VB	I-VP
O	1113	1116	the	the	DT	B-NP
O	1117	1126	potential	potential	NN	I-NP
O	1127	1129	of	of	IN	B-PP
O	1130	1134	this	this	DT	B-NP
O	1135	1143	scaffold	scaffold	NN	I-NP
O	1144	1147	for	for	IN	B-PP
O	1148	1161	encapsulation	encapsulation	NN	B-NP
O	1162	1164	of	of	IN	B-PP
O	1165	1170	guest	guest	NN	B-NP
O	1171	1180	molecules	molecule	NNS	I-NP
O	1180	1181	,	,	,	O
O	1182	1184	we	we	PRP	B-NP
O	1185	1189	made	make	VBD	B-VP
O	1190	1198	variants	variant	NNS	B-NP
O	1199	1201	at	at	IN	B-PP
O	1202	1210	residues	residue	NNS	B-NP
O	1211	1214	381	381	CD	B-NP
O	1215	1218	and	and	CC	I-NP
O	1219	1222	239	239	CD	I-NP
O	1223	1228	which	which	WDT	B-NP
O	1229	1236	altered	alter	VBD	B-VP
O	1237	1240	the	the	DT	B-NP
O	1241	1256	physicochemical	physicochemical	JJ	I-NP
O	1257	1267	properties	property	NNS	I-NP
O	1268	1270	of	of	IN	B-PP
O	1271	1274	the	the	DT	B-NP
O	1275	1281	hollow	hollow	JJ	I-NP
O	1282	1290	internal	internal	JJ	I-NP
O	1291	1297	cavity	cavity	NN	I-NP
O	1297	1298	.	.	.	O

O	1299	1304	These	These	DT	B-NP
O	1305	1312	mutants	mutant	NNS	I-NP
O	1312	1313	,	,	,	O
O	1314	1322	yielding	yield	VBG	B-VP
O	1323	1325	60	60	CD	B-NP
O	1326	1329	and	and	CC	I-NP
O	1330	1333	120	120	CD	I-NP
O	1334	1343	mutations	mutation	NNS	I-NP
O	1344	1350	within	within	IN	B-PP
O	1351	1355	this	this	DT	B-NP
O	1356	1362	cavity	cavity	NN	I-NP
O	1362	1363	,	,	,	O
O	1364	1373	assembled	assemble	VBN	B-VP
O	1374	1378	into	into	IN	B-PP
O	1379	1382	the	the	DT	B-NP
O	1383	1390	correct	correct	JJ	I-NP
O	1391	1403	architecture	architecture	NN	I-NP
O	1404	1407	and	and	CC	O
O	1408	1417	exhibited	exhibit	VBD	B-VP
O	1418	1422	high	high	JJ	B-NP
O	1423	1438	thermostability	thermostability	NN	I-NP
O	1439	1443	that	that	WDT	B-NP
O	1444	1447	was	be	VBD	B-VP
O	1448	1458	comparable	comparable	JJ	B-ADJP
O	1459	1461	to	to	TO	B-PP
O	1462	1465	the	the	DT	B-NP
O	1466	1470	wild	wild	JJ	I-NP
O	1470	1471	-	-	HYPH	I-NP
O	1471	1475	type	type	NN	I-NP
O	1476	1484	scaffold	scaffold	RB	B-ADVP
O	1484	1485	.	.	.	O

O	1486	1488	To	To	TO	B-VP
O	1489	1493	show	show	VB	I-VP
O	1494	1497	the	the	DT	B-NP
O	1498	1511	applicability	applicability	NN	I-NP
O	1512	1514	of	of	IN	B-PP
O	1515	1519	this	this	DT	B-NP
O	1520	1528	scaffold	scaffold	NN	I-NP
O	1528	1529	,	,	,	O
O	1530	1533	two	two	CD	B-NP
O	1534	1543	different	different	JJ	I-NP
O	1544	1555	fluorescent	fluorescent	JJ	I-NP
O	1556	1559	dye	dye	NN	I-NP
O	1560	1569	molecules	molecule	NNS	I-NP
O	1570	1574	were	be	VBD	B-VP
O	1575	1585	covalently	covalently	RB	I-VP
O	1586	1593	coupled	couple	VBN	I-VP
O	1594	1596	to	to	TO	B-PP
O	1597	1600	the	the	DT	B-NP
O	1601	1609	cysteine	cysteine	NN	I-NP
O	1610	1616	mutant	mutant	NN	I-NP
O	1617	1619	at	at	IN	B-PP
O	1620	1624	site	site	NN	B-NP
O	1625	1628	381	381	CD	I-NP
O	1628	1629	.	.	.	O

O	1630	1632	We	We	PRP	B-NP
O	1633	1644	demonstrate	demonstrate	VBP	B-VP
O	1645	1649	that	that	IN	B-SBAR
O	1650	1655	these	these	DT	B-NP
O	1656	1665	mutations	mutation	NNS	I-NP
O	1666	1669	can	can	MD	B-VP
O	1670	1679	introduce	introduce	VB	I-VP
O	1680	1683	non	non	AFX	B-NP
O	1683	1684	-	-	HYPH	I-NP
O	1684	1690	native	native	JJ	B-NP
O	1691	1704	functionality	functionality	NN	I-NP
O	1705	1708	and	and	CC	O
O	1709	1715	enable	enable	JJ	B-NP
O	1716	1725	molecular	molecular	JJ	I-NP
O	1726	1739	encapsulation	encapsulation	NN	I-NP
O	1740	1746	within	within	IN	B-PP
O	1747	1750	the	the	DT	B-NP
O	1751	1757	cavity	cavity	NN	I-NP
O	1758	1763	while	while	IN	B-SBAR
O	1764	1769	still	still	RB	B-ADVP
O	1770	1779	retaining	retain	VBG	B-VP
O	1780	1783	the	the	DT	B-NP
O	1784	1796	dodecahedral	dodecahedral	JJ	I-NP
O	1797	1806	structure	structure	NN	I-NP
O	1806	1807	.	.	.	O

O	1808	1811	The	The	DT	B-NP
O	1812	1821	unusually	unusually	RB	I-NP
O	1822	1828	robust	robust	JJ	I-NP
O	1829	1835	nature	nature	NN	I-NP
O	1836	1838	of	of	IN	B-PP
O	1839	1843	this	this	DT	B-NP
O	1844	1852	scaffold	scaffold	JJ	I-NP
O	1853	1856	and	and	CC	O
O	1857	1860	its	its	PRP$	B-NP
O	1861	1872	amenability	amenability	NN	I-NP
O	1873	1875	to	to	TO	B-PP
O	1876	1884	internal	internal	JJ	B-NP
O	1885	1892	changes	change	NNS	I-NP
O	1893	1899	reveal	reveal	VBP	B-VP
O	1900	1903	its	its	PRP$	B-NP
O	1904	1913	potential	potential	NN	I-NP
O	1914	1917	for	for	IN	B-PP
O	1918	1927	nanoscale	nanoscale	NN	B-NP
O	1928	1940	applications	application	NNS	I-NP
O	1940	1941	.	.	.	O

